Aurora Cannabis Inc. ACB
NASDAQ · United States · Process Industries
$3.90-0.13 (-3.23%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
The S&P/TSX Composite Index dropped to the lowest level in two months mid-morning Wednesday, with sh
Aurora is asking Alberta regulators to fix what it calls three deficiencies in Curaleaf’s $4 hostile bid, while Curaleaf says the complaints are technicalities and vows to keep fighting.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, today filed an application with the Alberta Securities Commission ("ASC') for an order requiring Curaleaf Holdings, Inc. ("Curaleaf") (TSX: CURA) (OTCQX: CURLF) to address several deficiencies Aurora has identified in its hostile bid Circular and to require Curaleaf to comply with securities law requirements.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.